AnswersPublished16 sources
Qureight Raises $20M Series B to Build AI Chest Foundation Model and Speed Lung Heart Trials
Qureight, a Cambridge based AI imaging company, raised $20 million in a Series B round led by Molten Ventures on July 29, 2026. The round was oversubscribed three lead investors submitted term sheets within six weeks, and Qureight chose to anchor to London based Molten Ventures over competing US offers.
Research answer
Key takeaways
- Qureight, a Cambridge based AI imaging company, raised $20 million in a Series B round led by Molten Ventures on July 29, 2026.
- The round was oversubscribed three lead investors submitted term sheets within six weeks, and Qureight chose to anchor to London based Molten Ventures over competing US offers.
- The global lung and heart clinical trials market is projected to reach $27.5 billion by 2030.
AI Prompt
openai.comCreate a landscape editorial hero image for this Studio Global article: What key details were announced about Qureight's $20 million Series B funding round in July 2026, including the lead investor, total funding. Article summary: Now let me get the official press release from Qureight's website for the mostHere are the key details from Qureight's Series B announcement on July 29, 2026, drawn from the company's official press release.. Topic tags: general, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fake numbers, c
On July 29, 2026, Cambridge-based Qureight announced it closed a $20 million Series B financing round, led by Molten Ventures, with participation from existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension . The round was oversubscribed: three lead investors submitted term sheets within six weeks, and Qureight chose to anchor to London-based Molten Ventures over competing US offers
.
What Qureight Does
Qureight provides an end-to-end imaging platform for clinical trials focused on lung and heart disease. The platform covers three integrated offerings :
- Global imaging CRO services that improve image handling in trials, enabling rapid site onboarding and patient inclusion decisions.
- Proprietary AI lung image biomarkers that quantify compartment-specific structural changes indicating disease progression.
- Data science products including synthetic control arms, which enable comparisons to real trial arms and reduce study costs and duration.
The company claims one imaging decision that once took two weeks now takes 48 hours using its platform .
Expansion into New Disease Areas
Qureight's existing focus has been on lung fibrosis. The Series B funding will support new disease models in four additional areas :
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
People also ask
What is the short answer to "Qureight Raises $20M Series B to Build AI Chest Foundation Model and Speed Lung Heart Trials"?
Qureight, a Cambridge based AI imaging company, raised $20 million in a Series B round led by Molten Ventures on July 29, 2026.
What are the key points to validate first?
Qureight, a Cambridge based AI imaging company, raised $20 million in a Series B round led by Molten Ventures on July 29, 2026. The round was oversubscribed three lead investors submitted term sheets within six weeks, and Qureight chose to anchor to London based Molten Ventures over competing US offers.
What should I do next in practice?
The global lung and heart clinical trials market is projected to reach $27.5 billion by 2030.
Sources
- qureight.comQureight closes $20 million Series B financing
- fundup.aiQureight $20M Series B Funding (2026) | Investors & Contacts
- entrepreneurloop.comQureight Raises $20M to Build AI Chest Foundation Model
- healthcare.digitalAn Analysis of Qureight's $20 Million Series B Financing
- fundediq.coQureight Funding
- thenextweb.com